[go: up one dir, main page]

SE8500965D0 - Mellanprodukter for framstellning av beta-laktamasinhibitorer - Google Patents

Mellanprodukter for framstellning av beta-laktamasinhibitorer

Info

Publication number
SE8500965D0
SE8500965D0 SE8500965A SE8500965A SE8500965D0 SE 8500965 D0 SE8500965 D0 SE 8500965D0 SE 8500965 A SE8500965 A SE 8500965A SE 8500965 A SE8500965 A SE 8500965A SE 8500965 D0 SE8500965 D0 SE 8500965D0
Authority
SE
Sweden
Prior art keywords
beta
alpha
lactama
intermediates
inhibitors
Prior art date
Application number
SE8500965A
Other languages
English (en)
Other versions
SE461528B (sv
Inventor
W E Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE8500965D0 publication Critical patent/SE8500965D0/sv
Publication of SE461528B publication Critical patent/SE461528B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8500965A 1979-09-26 1985-02-27 Mellanprodukter foer framstaellning av acetoximetyl-penamfoereningar, som aer anvaendbara som -laktamasinhibitorer SE461528B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/079,127 US4256733A (en) 1979-09-26 1979-09-26 Acetoxymethyl penam compounds as β-lactamase inhibitors

Publications (2)

Publication Number Publication Date
SE8500965D0 true SE8500965D0 (sv) 1985-02-27
SE461528B SE461528B (sv) 1990-02-26

Family

ID=22148609

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8005714A SE449865B (sv) 1979-09-26 1980-08-13 Acetoximetyl-pencillansyra derivat och dess anvendning sasom beta-laktamasinhibitorer
SE8500965A SE461528B (sv) 1979-09-26 1985-02-27 Mellanprodukter foer framstaellning av acetoximetyl-penamfoereningar, som aer anvaendbara som -laktamasinhibitorer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8005714A SE449865B (sv) 1979-09-26 1980-08-13 Acetoximetyl-pencillansyra derivat och dess anvendning sasom beta-laktamasinhibitorer

Country Status (36)

Country Link
US (1) US4256733A (sv)
JP (1) JPS6016958B2 (sv)
KR (1) KR840000796B1 (sv)
AR (1) AR224547A1 (sv)
AT (1) AT366384B (sv)
AU (1) AU517074B2 (sv)
BE (1) BE885389A (sv)
CA (1) CA1150242A (sv)
CH (1) CH645646A5 (sv)
CS (1) CS212284B2 (sv)
DD (1) DD153123A5 (sv)
DE (1) DE3035995C2 (sv)
DK (1) DK404980A (sv)
EG (1) EG14888A (sv)
ES (1) ES8106528A1 (sv)
FI (2) FI67552C (sv)
FR (1) FR2465736A1 (sv)
GB (2) GB2059420B (sv)
GR (1) GR70065B (sv)
HU (1) HU183212B (sv)
IE (2) IE50506B1 (sv)
IL (1) IL61117A (sv)
IN (1) IN154557B (sv)
IT (1) IT1132754B (sv)
LU (1) LU82795A1 (sv)
MX (1) MX6580E (sv)
NL (1) NL185923C (sv)
NO (2) NO160370C (sv)
NZ (1) NZ195058A (sv)
PH (1) PH15697A (sv)
PL (1) PL126949B1 (sv)
PT (1) PT71837B (sv)
SE (2) SE449865B (sv)
SU (1) SU959628A3 (sv)
YU (1) YU41733B (sv)
ZA (1) ZA805132B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364957A (en) * 1979-09-26 1982-12-21 Pfizer Inc. Bis-esters of alkanediols as antibacterial agents
US4511512A (en) * 1980-05-01 1985-04-16 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Produktionsaktiensel skab) Substantially pure dicyclohexyl ammonium 6-β-bromo-penicillanate
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4361513A (en) * 1980-12-11 1982-11-30 Pfizer Inc. Esters of penicillanic acid sulfone
US4558042A (en) * 1981-05-06 1985-12-10 Farmitalia Carlo Erba S.P.A. β-Lactam-containing antibacterial agents and β-lactamase inhibitors
ZA826687B (en) * 1981-09-14 1983-07-27 Pfizer Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl 5(r)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
JPS58185589A (ja) * 1982-04-23 1983-10-29 Taiho Yakuhin Kogyo Kk ペニシリン誘導体
JPS62198687A (ja) * 1986-02-27 1987-09-02 Taiho Yakuhin Kogyo Kk 2β−置換チオメチルペニシリン誘導体
US4861768A (en) * 1986-02-27 1989-08-29 Taiho Pharmaceutical Company, Limited 2 β-substituted thiomethylpenicillin derivatives and their preparation and use
SK63894A3 (en) * 1991-12-19 1995-03-08 Novo Nordisk As Method of preparation of beta-lactam antibiotic
CN115385934A (zh) * 2022-10-26 2022-11-25 北京纳百生物科技有限公司 一种舒巴坦半抗原及其合成方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE648188A (sv) 1963-05-29 1964-09-16
IN149747B (sv) 1977-06-07 1982-04-03 Pfizer

Also Published As

Publication number Publication date
IE50506B1 (en) 1986-04-30
PT71837A (en) 1980-10-01
IE801095L (en) 1981-01-09
BE885389A (fr) 1981-03-25
PL226868A1 (sv) 1981-10-16
SU959628A3 (ru) 1982-09-15
NO802836L (no) 1981-03-27
AU6271380A (en) 1981-04-09
IN154557B (sv) 1984-11-10
GB2059420A (en) 1981-04-23
AT366384B (de) 1982-04-13
NL185923C (nl) 1990-08-16
NO160370B (no) 1989-01-02
GR70065B (sv) 1982-07-26
PL126949B1 (en) 1983-09-30
YU244980A (en) 1983-02-28
GB8319784D0 (en) 1983-08-24
JPS6016958B2 (ja) 1985-04-30
DD153123A5 (de) 1981-12-23
NZ195058A (en) 1982-12-07
JPS5657788A (en) 1981-05-20
HU183212B (en) 1984-04-28
IL61117A (en) 1983-10-31
PT71837B (en) 1981-07-09
FI67552C (fi) 1985-04-10
GB2059420B (en) 1984-03-14
FI67854C (fi) 1985-06-10
EG14888A (en) 1985-06-30
NL185923B (nl) 1990-03-16
IE50507B1 (en) 1986-04-30
FR2465736B1 (sv) 1982-04-30
DE3035995A1 (de) 1981-04-02
US4256733A (en) 1981-03-17
AR224547A1 (es) 1981-12-15
NO160370C (no) 1989-04-12
ATA474680A (de) 1981-08-15
FI67854B (fi) 1985-02-28
ES495354A0 (es) 1981-08-16
FI803028A7 (fi) 1981-03-27
LU82795A1 (fr) 1981-04-17
ZA805132B (en) 1981-12-30
CS212284B2 (en) 1982-03-26
PH15697A (en) 1983-03-14
NO831082L (no) 1981-03-27
ES8106528A1 (es) 1981-08-16
IL61117A0 (en) 1980-11-30
KR840000796B1 (ko) 1984-06-12
NO160299B (no) 1988-12-27
KR830003494A (ko) 1983-06-20
FI840367L (fi) 1984-01-30
SE449865B (sv) 1987-05-25
NO160299C (no) 1989-04-05
IT8024920A0 (it) 1980-09-25
MX6580E (es) 1985-07-24
YU41733B (en) 1987-12-31
SE461528B (sv) 1990-02-26
CH645646A5 (fr) 1984-10-15
FI67552B (fi) 1984-12-31
IE801998L (en) 1981-03-26
AU517074B2 (en) 1981-07-09
NL8005344A (nl) 1981-03-30
DE3035995C2 (de) 1985-01-10
SE8005714L (sv) 1981-03-27
GB2125037B (en) 1984-08-01
FI840367A0 (fi) 1984-01-30
GB2125037A (en) 1984-02-29
CA1150242A (en) 1983-07-19
FR2465736A1 (fr) 1981-03-27
IT1132754B (it) 1986-07-02
DK404980A (da) 1981-03-27

Similar Documents

Publication Publication Date Title
SE8305916L (sv) Mellanprodukter for framstellning av penicillansyra-1,1-dioxider
AU6354880A (en) Derivatives of 6beta-hydroxyalkylpenicillanic acids as beta-lactamase inhibitors
ZA817696B (en) N-substituted omega-(2-oxo-4-imidazolin-1-yl)alcanoic acids,salts and esters thereof,process for producing the same and these active agents containing pharmaceutical compounds
SE8500965D0 (sv) Mellanprodukter for framstellning av beta-laktamasinhibitorer
IE780899L (en) Azetidinopyrrole derivatives
IL90056A (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
SE8404308D0 (sv) Polyprenylkarboxylsyraamider, forfarande for deras framstellning samt farmaceutiska kompositioner innehallande dessa foreningar
NZ201895A (en) 2-beta-substituted-2-alpha-methyl-(5r)-penam-3-alpha-carboxylic acid 1,1-dioxides;intermediates and pharmaceutical compositions
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
NO810758L (no) Fremgangsmaate for oekning av den orale absorpsjon av beta-lactamantibiotika
DE3062787D1 (en) Novel process for the preparation of 6-aminopenicillanic acid-1,1-dioxide and its salts
SE7906681L (sv) Ftalazonderivat
ES476259A1 (es) Un procedimiento para la preparacion de un compuesto.
GB2014574A (en) Lactam Compounds
FI830192A0 (fi) Foerfarande foer framstaellning av penicillinderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8500965-2

Effective date: 19910131

Format of ref document f/p: F